Relative to internal DQ-OVA- control, there was a significant downregulation of CD86 on DQ-OVA+ MPs in the tumor, while upregulation of CD80 was observed on DQ-OVA+ colonic MPs (Figure 5C). This evidence concerns the gene CD86 and neoplasm.